Macatangay, BJC and Szajnik, ME and Whiteside, TL and Riddler, SA and Rinaldo, CR
(2010)
Regulatory T cell suppression of gag-specific CD8<sup>+</sup> T cell polyfunctional response after therapeutic vaccination of HIV-1-infected patients on ART.
PLoS ONE, 5 (3).
Abstract
We tested the hypothesis that therapeutic vaccination against HIV-1 can increase the frequency and suppressive function of regulatory, CD4+ T cells (Treg), thereby masking enhancement of HIV-1-specific CD8+ T cell response. HIV-1-infected subjects on antiretroviral therapy (N = 17) enrolled in a phase I therapeutic vaccine trial received 2 doses of autologous dendritic cells (DC) loaded with HIV-1 peptides. The frequency of CD4+CD25hiFOXP3+ Treg in blood was determined prior to and after vaccination in subjects and normal controls. Polyfunctional CD8+ T cell responses were determined pre- and post-vaccine (N = 7) for 5 immune mediators after in vitro stimulation with Gag peptide, staphylococcal enterotoxin B (SEB), or medium alone. Total vaccine response (post-vaccine-pre-vaccine) was compared in the Treg(+) and Treg-depleted (Treg-) sets. After vaccination, 12/17 subjects showed a trend of increased Treg frequency (P = 0.06) from 0.74% to 1.2%. The increased frequency did not correlate with CD8+ T cell vaccine response by enzyme linked immunosorbent assay for interferon c production. Although there was no significant change in CD8+ T cell polyfunctional response after vaccination, Treg depletion increased the polyfunctionality of the total vaccine response (P = 0.029), with a >2-fold increase in the percentage of CD8+ T cells producing multiple immune mediators. In contrast, depletion of Treg did not enhance polyfunctional T cell response to SEB, implying specificity of suppression to HIV-1 Gag. Therapeutic immunization with a DC-based vaccine against HIV-1 caused a modest increase in Treg frequency and a significant increase in HIV-1-specific, Treg suppressive function. The Treg suppressive effect masked an increase in the vaccine-induced anti-HIV-1-specific polyfunctional response. The role of Treg should be considered in immunotherapeutic trials of HIV-1 infection. © 2010 Macatangay et al.
Share
Citation/Export: |
|
Social Networking: |
|
Details
Item Type: |
Article
|
Status: |
Published |
Creators/Authors: |
|
Contributors: |
Contribution | Contributors Name | Email | Pitt Username | ORCID ![](/images/orcid_id_24x24.png) |
---|
Editor | Kallas, Esper Georges | UNSPECIFIED | UNSPECIFIED | UNSPECIFIED |
|
Centers: |
Other Centers, Institutes, Offices, or Units > Pittsburgh Cancer Institute |
Date: |
1 December 2010 |
Date Type: |
Publication |
Journal or Publication Title: |
PLoS ONE |
Volume: |
5 |
Number: |
3 |
DOI or Unique Handle: |
10.1371/journal.pone.0009852 |
Schools and Programs: |
School of Public Health > Infectious Diseases and Microbiology |
Refereed: |
Yes |
MeSH Headings: |
AIDS Vaccines--therapeutic use; Anti-Retroviral Agents; CD8-Positive T-Lymphocytes--cytology; Dendritic Cells--cytology; Enzyme-Linked Immunosorbent Assay--methods; Female; HIV Infections--immunology; HIV Infections--metabolism; HIV-1--genetics; Humans; Immunophenotyping; Interferon-gamma--metabolism; Leukocytes, Mononuclear--cytology; Male; T-Lymphocytes, Regulatory--immunology; gag Gene Products, Human Immunodeficiency Virus--metabolism |
Other ID: |
NLM PMC2844424 |
PubMed Central ID: |
PMC2844424 |
PubMed ID: |
20352042 |
Date Deposited: |
03 Aug 2012 18:56 |
Last Modified: |
22 Jun 2021 16:55 |
URI: |
http://d-scholarship.pitt.edu/id/eprint/13342 |
Metrics
Monthly Views for the past 3 years
Plum Analytics
Altmetric.com
Actions (login required)
![View Item View Item](/style/images/action_view.png) |
View Item |